CHALEX

Oxford Molecular aims to provide computational chemistry and molecular graphics to European and U.S. markets.

FlexGen is working towards the commercialization of a fast and flexible custom microarray synthesis instrument for genomic selection in sequencing and other applications.

Axela is delivering on its mission to provide a simple and effective approach to personalized medicine by exploiting the dotLab System in research markets today to generate tomorrow's diagnostics. This strategy of offering a common technology platform to both markets aims to provide a opportunity to capitalize on discoveries. The approach has already resulted in applications with the potential to address segments of the large, underserved markets of oncology and cardiology that will be the focus of two funded clinical trials this summer and growing installed customer base. For a time these leading clinical researchers can use the direct understanding of protein interactions to develop quantitative assays on a single platform. dot technology has shortened the transition from protein discovery to application. The ability to measure biomolecular complexes in real-time aims to provide for new approaches to disease management.

KPS Technologies produces cyanine dyes that absorb and fluoresce at near- infrared wavelengths. These molecules are useful as detection units since virtually all organic materials including biological tissues are penetrated by NIR radiation. Potential applications are quite varied but those of interest are diagnostic ones including protein labeling, immunoassays and DNA sequencing. The major market for these compounds will be instrument manufacturers. Custom made kits are available upon request.

Biocolor offers assay kits (eg Collagen and Elastin) for tissue culture laboratories.

Neuromedical Systems, Inc. a development stage company develops, manufactures and markets systems for computer assisted screening of pap smears and other cytological specimans. The company's product papnet testing system is used in laboratories in detection of abnormal cells on pap smears. Papnet is also used in detection of bladder and lung cancer. During the year, the company acquired New System International, Ltd. The company has international operations in Europe, Israel, Asia and Australia.